Stay updated with breaking news from Lobe Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it expects to have two active Investigational New Drug applications in progress with the US Food and Drug...
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering
Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it has received regulatory clearance to conduct a Phase 1 study evaluating the safety and pharmacokinetics of...
Vancouver, British Columbia--(Newsfile Corp. - October 5, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
Resignation of Board Chairman, Jonathan Gilbert and Shares for Debt Transactions Vancouver, British Columbia--(Newsfile Corp. - October 3, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"